市場調查報告書
商品編碼
1396595
避孕藥具市場 - 按產品(藥物、器材)、按年齡層(15-44 歲、44 歲以上)、按配銷通路(醫院藥房、零售藥房、線上管道),- 全球預測,2023-2032 年Contraceptives Market - By Product (Drugs, Devices), By Age Group (15-44 Years, above 44 Years), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channels), - Global Forecast, 2023-2032 |
由於人們對計劃生育的認知不斷增強以及人口控制的重要性,預計從 2023 年到 2032 年,避孕藥具市場規模將以 6.3% 的CAGR擴大。對婦女健康、教育和賦權的日益關注導致對避孕藥具的需求增加。避孕技術的不斷進步正在為開發更方便、更有效的消費方法鋪平道路。例如,2023年7月,美國FDA批准Opil(炔諾孕酮)片劑用於非處方用途,這標誌著美國首次授權每日口服避孕藥無需處方即可在非處方藥中使用。
此外,性傳染感染(STI)盛行率的上升鼓勵了屏障方法的使用。為了追求職業而延遲生育和計劃生育的趨勢不斷上升,也推動了避孕藥具的採用。政府為促進生殖健康而採取的措施和宣傳活動的大量湧入也對市場成長產生了積極影響。
避孕藥具市場按產品、年齡層、配銷通路和地區分類。
根據產品,預計 2023 年至 2032 年藥品領域的產業規模複合CAGR為 3.9%。這一成長可歸因於荷爾蒙和非荷爾蒙避孕藥研發活動的增加。人們對計劃生育的認知不斷提高、製藥技術的進步以及婦女健康措施的不斷擴大將推動產品需求。
預計 2023 年至 2032 年,44 歲以上年齡層的避孕藥具市佔率將以 5.6% 的CAGR成長。這可以歸因於延遲生育的趨勢上升、對計劃生育意識的增強以及老年人對有效節育方法的更大渴望。針對該年齡層特定需求的避孕選擇的不斷進步也將促進該細分市場的成長。
從地區來看,由於計劃生育意識不斷增強以及政府促進生殖健康的舉措不斷湧現,亞太地區避孕藥具市場規模預計從 2023 年到 2032 年將以 7.9% 的CAGR成長。此外,文化轉變、城市化以及對婦女教育和賦權的日益關注將推動整個地區對避孕藥具的需求。
Contraceptives market size is projected to expand at 6.3% CAGR from 2023 to 2032, on account of the increasing awareness about family planning and the importance of population control. The growing focus on women health, education, and empowerment is contributing to higher demand for contraceptives. The rising advancement in contraceptive technologies is making way for the development of more convenient and effective methods for consumption. For instance, in July 2023, the U.S. FDA granted approval for Opill (norgestrel) tablets for nonprescription use, marking the first authorization of a daily oral contraceptive for over-the-counter use in the U.S. without a prescription.
Moreover, the rising prevalence of sexually transmitted infections (STIs) is encouraging the use of barrier methods. The rising trend of delayed parenthood and family planning for career pursuits is also driving the adoption of contraceptives. The influx of government initiatives and awareness campaigns for promoting reproductive health is also positively affecting the market growth.
The contraceptives market is segregated into product, age group, distribution channel, and region.
Based on product, the industry size from the drugs segment is projected to depict 3.9% CAGR from 2023 to 2032. The growth can be ascribed to the increasing R&D activities in hormonal and non-hormonal contraceptive drugs. The rising awareness about family planning, the higher advancements in pharmaceutical technologies, and the expanding initiatives for women health will fuel the product demand.
Contraceptives market share from the above 44 years age group segment is projected to rise at 5.6% CAGR during 2023-2032. This can be attributed to the rising trend of delayed parenthood, increased awareness of family planning, and the greater desire for effective birth control methods among older individuals. The growing advancements in contraceptive options tailored to the specific needs of this age group will also boost the segment growth.
Regionally, the Asia Pacific contraceptives market size is projected to grow at 7.9% CAGR from 2023 to 2032 due to the increasing awareness of family planning and the influx of government initiatives for promoting reproductive health. Additionally, cultural shifts, urbanization, and the growing focus on women education and empowerment will fuel the demand for contraceptives across the region.